Ambivalent Copper: Mechanistically Distinct Immune Effects Driving Innovation in Cancer Nanomedicine

Area of Science:

• Biomedical Science
• Cancer Research
• Immunology

Background:

• Copper (Cu) is vital for cellular functions, but its dysregulation is implicated in cancer.
• Altered copper levels impact immune pathways, including inflammation, cell death, and immune evasion.
• Copper influences programmed death ligand 1 (PD-L1) expression and immunogenic cell death, affecting anti-cancer immunity.

Purpose of the Study:

• To review the dual role of copper in cancer and immunity.
• To explore the potential of copper-based nanomedicines in cancer therapy.
• To discuss the conversion of immunologically "cold" tumors to "hot" tumors using copper.

Main Methods:

• Literature review of copper's role in cancer and immunity.
• Analysis of copper's impact on immunoregulatory pathways.
• Exploration of copper-based nanomedicine strategies.

Main Results:

• Copper has complex effects, promoting immunosuppression via PD-L1 but also immunogenic cell death.
• Copper-based nanomedicines can selectively deliver copper to tumors, inducing cell death.
• Copper modulation of immune pathways offers therapeutic potential.

Conclusions:

• Copper-based nanomedicines show promise for enhancing cancer immunotherapy.
• Targeting copper metabolism could overcome resistance to immunotherapy.
• Integrating copper delivery with immunotherapy may improve treatment efficacy for "cold" tumors.